Summary
Rhea J. Posedel, a director at Aehr Test Systems (NASDAQ: AEHR), completed a sale of 30,000 shares of the company’s common stock on April 9, 2026. The shares were sold at $70 each, generating proceeds of $2,100,000. At the time of the transaction the stock was trading near its 52-week high of $72.50, after a one-year return of 727%.
Transaction details and ownership
The sale was reported to the Securities and Exchange Commission on a Form 4. After the disposition, Posedel directly holds 71,163 shares, a figure that includes unvested restricted stock units. In addition to her direct holdings, Posedel indirectly owns 426,979 shares via a trust.
Recent financial results
Aehr Test Systems released its third-quarter fiscal 2026 financials, which presented a mix of outcomes. The company recorded an earnings per share (EPS) of -$0.05, outperforming analysts’ consensus expectation of -$0.07. Revenue for the quarter came in at $10.3 million, underperforming the forecasted $10.8 million.
Despite the revenue shortfall, the company reported quarterly bookings of $37.2 million, producing a book-to-bill ratio in excess of 3.5x. The sizable bookings figure was noted as a noteworthy datapoint in the quarter.
Analyst response
In light of these results, Lake Street adjusted its outlook by raising its price target on Aehr Test Systems to $56 from $50 while maintaining a Buy rating. The firm cited the company’s strong bookings momentum as a favorable factor underpinning the rating and target revision.
Context and constraints
The sale by a company director and the mixed quarterly results are presented as reported. No additional inferences about motivations, future performance, or causation are made beyond the disclosed facts. The transaction and the fiscal quarter metrics are derived from the Form 4 filing and the company’s reported financial figures.
Key points
- Director sale: Rhea J. Posedel sold 30,000 shares on April 9, 2026, at $70 per share, for $2.1 million.
- Ownership after sale: Posedel directly owns 71,163 shares (including unvested RSUs) and indirectly owns 426,979 shares via trust.
- Quarterly results: Q3 fiscal 2026 EPS of -$0.05 beat expectations, revenue of $10.3 million missed the $10.8 million forecast, and bookings reached $37.2 million with a book-to-bill over 3.5x.
Risks and uncertainties
- Revenue miss: Reported revenue of $10.3 million fell short of the $10.8 million analysts expected - a factor that can affect market perception of near-term top-line strength.
- Insider sale: The director sale reduced direct holdings; the public filings document the transaction but do not provide reasons for the sale.
- Booking conversion: While bookings were strong at $37.2 million, the translation of bookings into recognized revenue is not detailed in the filings provided.
Disclosure
No additional disclosures are included in the body of this article.